Cobimetinib‐induced “dropped head syndrome” and subsequent disease management in an Erdheim‐Chester patient

Our rechallenge of cobimetinib in an Erdheim‐Chester Disease (ECD) patient for the rare adverse effect, “dropped head syndrome,” with a previously unexplored cobimetinib regimen was successful. Similar to other experiences with targeted agents in ECD, dosing of cobimetinib may vary to mitigate toxic...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Clin Case Rep
Egile Nagusiak: King, Amber C., Diamond, Eli L., Orozco, Jennifer S., Morse, Hannah R., Ouyang, Linda L., Schöder, Heiko, Rampal, Raajit K.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: John Wiley and Sons Inc. 2019
Gaiak:
Case Reports
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6787838/
https://ncbi.nlm.nih.gov/pubmed/31624624
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ccr3.2297
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak